Literature DB >> 10703665

Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells.

José G VAN DEN Berg1, Jan Aten1, M Anwar Chand1, Nike Claessen1, Lisette Dijkink2, John Wijdenes3, Fadi G Lakkis4, Jan J Weening1.   

Abstract

In minimal change nephrosis (MCN), proteinuria is associated with structural changes of the glomerular visceral epithelial cells (GVEC). The occurrence of MCN has been associated with 2 lymphocyte-dependent conditions. To examine a direct role for type 2 cytokines in GVEC injury, the expression of interleukin (IL)-4/IL-13 receptors by GVEC and direct effects of IL-4 and IL-13 on GVEC were studied. Reverse transcription-PCR showed that isolated human and rat glomeruli and cultured human and rat GVEC expressed mRNA for IL-4Ralpha, IL-13Ralpha1, and IL-13Ralpha2. Protein expression of [L-4Ralpha and IL-13Ralpha2 by GVEC in human kidney biopsies and by cultured human GVEC was detected by immunohistochemistry. Western blotting demonstrated phosphorylation of STAT6 in cultured GVEC upon incubation with IL-4 or IL-13. This indicated signal transduction via the heterodimeric receptor complex IL-4R2, which is composed of the IL-4Ralpha and the IL-13Ralpha1. Direct effects on GVEC function were examined in monolayer experiments. IL-4 and IL-13 dose-dependently decreased transepithelial electrical resistance of monolayers of rat GVEC to approximately 30 and 40% of baseline values, respectively. The transepithelial electrical resistance decrease was associated with a significant increase in short-circuit current, whereas no changes were observed in the transmonolayer flux of the macromolecules horseradish peroxidase (molecular weight, 44 kD) and 14C-mannitol (molecular weight, 182 Da). No changes in cell structure were observed with electron microscopy. It is concluded that by binding to specific IL-4/ IL-13 receptors, IL-4 and IL-13 can exert specific effects on GVEC function, which could be of pathogenetic relevance for glomerular injury in MCN.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10703665     DOI: 10.1681/ASN.V113413

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  25 in total

1.  Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis.

Authors:  D Kerjaschki
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 2.  What has the immune system got against the glomerular podocyte?

Authors:  P W Mathieson
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 3.  Immunopathogenesis of idiopathic nephrotic syndrome with relapse.

Authors:  Djillali Sahali; Kelhia Sendeyo; Melanie Mangier; Vincent Audard; Shao Yu Zhang; Philippe Lang; Mario Ollero; Andre Pawlak
Journal:  Semin Immunopathol       Date:  2014-01-09       Impact factor: 9.623

4.  LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile.

Authors:  Tarak Srivastava; Mukut Sharma; Kok-Hooi Yew; Ram Sharma; R Scott Duncan; Moin A Saleem; Ellen T McCarthy; Alexander Kats; Patricia A Cudmore; Uri S Alon; Christopher J Harrison
Journal:  J Cell Commun Signal       Date:  2012-11-17       Impact factor: 5.782

5.  Synaptopodin is upregulated by IL-13 in eosinophilic esophagitis and regulates esophageal epithelial cell motility and barrier integrity.

Authors:  Mark Rochman; Jared Travers; J Pablo Abonia; Julie M Caldwell; Marc E Rothenberg
Journal:  JCI Insight       Date:  2017-10-19

6.  B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement.

Authors:  Alfred Hj Kim; Jun-Jae Chung; Shreeram Akilesh; Ania Koziell; Sanjay Jain; Jeffrey B Hodgin; Mark J Miller; Thaddeus S Stappenbeck; Jeffrey H Miner; Andrey S Shaw
Journal:  JCI Insight       Date:  2017-11-02

7.  Implication of serum IgE in childhood nephrotic syndrome.

Authors:  You-Lin Tain; Tsung-Yi Chen; Kuender D Yang
Journal:  Pediatr Nephrol       Date:  2003-10-31       Impact factor: 3.714

Review 8.  Minimal change nephropathy and focal segmental glomerulosclerosis.

Authors:  Peter W Mathieson
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

9.  Efficacy of zinc supplements in reducing relapses in steroid-sensitive nephrotic syndrome.

Authors:  Sasi Arun; Shinjini Bhatnagar; Shina Menon; Savita Saini; Pankaj Hari; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2009-04-04       Impact factor: 3.714

10.  T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy.

Authors:  S R Chintalacharuvu; M Yamashita; N Bagheri; T G Blanchard; J G Nedrud; M E Lamm; Y Tomino; S N Emancipator
Journal:  Clin Exp Immunol       Date:  2008-07-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.